Improving Medication‐Related Outcomes in Chronic Liver Disease
Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medicat...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2020-11-01
|
| Series: | Hepatology Communications |
| Online Access: | https://doi.org/10.1002/hep4.1612 |